Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Heart failure remains one of the leading causes of mortality and hospitalizations in the US that not only impacts quality of life but also poses a significant public health burden. The majority of affected patients are admitted with signs and symptoms of congestion. Despite the initial enthusiasm, traditional remote monitoring strategies focusing primarily on weight gain failed to improve clinical outcomes. Implantable pulmonary artery pressure sensors provide earlier and actionable data, but most patients would favor forgoing an invasive procedure in favor of an alternative, non-invasive monitoring platform. Several devices utilizing different combinations of multiparameter monitoring to reliably detect congestion have recently been developed and are undergoing testing in the clinical setting. Combining these sensors with the power of artificial intelligence and machine learning has the potential to revolutionize remote patient monitoring and early congestion detection and to facilitate timely interventions by the care team to prevent hospitalization. This manuscript provides an objective review of novel, noninvasive, multiparameter remote monitoring platforms that may be tailored to individual heart failure phenotypes, aiming to improve quality of life and survival.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10741-024-10441-7DOI Listing

Publication Analysis

Top Keywords

heart failure
12
quality life
8
remote monitoring
8
monitoring
6
noninvasive biometric
4
biometric monitoring
4
monitoring technologies
4
technologies patients
4
patients heart
4
failure heart
4

Similar Publications

Background: Fine particulate matter (PM) has been previously linked to cardiovascular diseases (CVDs). PM is a mixture of components, each of which has its own toxicity profile which are not yet well understood. This study explores the relationship between long-term exposure to PM components and hospital admissions with CVDs in the Medicare population.

View Article and Find Full Text PDF

Background: Pulmonary hypertension is associated with cardiovascular events, but when assessed at rest, it has limited sensitivity. Pulmonary vascular reserve can be assessed noninvasively using exercise echocardiography, but this has not been studied in adults with coarctation of aorta (COA). We hypothesized that adults with COA had worse pulmonary vascular reserve compared to controls, and that impaired pulmonary vascular reserve was associated with clinical indices of disease severity independent right ventricular (RV) indices at rest.

View Article and Find Full Text PDF

Background: Allopurinol, the most prescribed urate-lowering drug, is a known cause of severe cutaneous adverse reactions. We aimed to develop and validate a model to assess the risk of allopurinol-induced severe cutaneous adverse reactions in adults newly prescribed allopurinol.

Methods: In this retrospective new-user cohort study, we developed and validated a prognostic model using primary care, hospitalisation, and mortality data extracted from the UK Clinical Practice Research Datalink (CPRD) primary care database, for the period Jan 1, 2001, to March 29, 2021.

View Article and Find Full Text PDF

Comparison of spontaneous breathing test techniques for heart failure patients: A single-center, prospective, open-label, randomized controlled study.

Heart Lung

September 2025

The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China; Department of Critical Care Medicine, General Hospital of Southern Theatre Command of Chinese PLA, Guangzhou 510010, China; Guangdong Branch Center, National Clinical Research Center for Geriatric Diseases,

Background: Standardized spontaneous breathing trial (SBT) techniques for patients with heart failure (HF) are lacking.

Objectives: To compare the efficacy of low-level pressure-supported ventilation (PSV) and T-piece SBT techniques in patients with HF.

Methods: This single-center, prospective, open-label, randomized controlled study enrolled mechanically ventilated adults with stage B HF (Nov 2022-Apr 2024).

View Article and Find Full Text PDF